Trials / Completed
CompletedNCT02343497
Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidaemia
Randomized, Double-blind, Placebo-controlled, Parallel-group Design, Monocentric Study on Lipid-lowering Effects of an Astaxanthin Supplement in Volunteers With Mild Dyslipidemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Ajinomoto Foods Europe SAS · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate whether astaxanthin supplementation can impact triglyceride plasmatic concentrations in volunteers presenting mild dyslipidemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Astaxanthin | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-09-01
- Completion
- 2015-11-01
- First posted
- 2015-01-22
- Last updated
- 2018-01-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02343497. Inclusion in this directory is not an endorsement.